君实生物

- 688180

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
君实生物(688180) 利润表
单位:万元
报表日期2026-03-312025-12-312025-09-302025-06-302025-03-31
一、营业总收入72,628.78249,842.03180,588.01116,838.3950,059.15
营业收入72,628.78249,842.03180,588.01116,838.3950,059.15
二、营业总成本86,187.80344,436.32247,316.31165,910.7778,253.92
营业成本14,697.5446,650.4734,948.4923,297.329,390.10
营业税金及附加613.762,303.501,701.031,252.86596.18
销售费用25,177.24105,299.0176,827.6648,734.3422,568.45
管理费用13,864.0149,443.7230,990.3419,513.809,702.40
财务费用3,585.716,527.304,633.322,554.68939.24
研发费用28,249.54134,212.3298,215.4770,557.7835,057.55
资产减值损失----------
公允价值变动收益-1,336.205,721.035,801.585,551.38-28.92
投资收益12,089.50-10,641.68-3,885.08-2,028.24-1,036.99
其中:对联营企业和合营企业的投资收益-2,012.04-11,610.24-4,616.26-2,520.91-1,229.37
汇兑收益----------
三、营业利润-2,858.79-99,946.34-67,105.82-47,501.11-28,171.59
加:营业外收入15.8977.7349.7717.490.69
减:营业外支出941.372,458.822,183.261,037.54512.81
其中:非流动资产处置损失----------
四、利润总额-3,784.26-102,327.43-69,239.31-48,521.16-28,683.71
减:所得税费用558.28-1,388.09-1,808.33-1,953.82-2,725.07
五、净利润-4,342.54-100,939.34-67,430.99-46,567.34-25,958.64
归属于母公司所有者的净利润-2,056.40-87,517.43-59,570.02-41,269.56-23,487.62
少数股东损益-2,286.14-13,421.91-7,860.97-5,297.78-2,471.02
六、每股收益
基本每股收益(元/股)-0.0200-0.8700-0.6000-0.4200-0.2400
稀释每股收益(元/股)-0.0200-0.8700-0.6000-0.4200-0.2400
七、其他综合收益592.26-675.03-14.66-1,591.62-1,020.46
八、综合收益总额-3,750.29-101,614.37-67,445.65-48,158.96-26,979.11
归属于母公司所有者的综合收益总额-1,464.15-88,192.46-59,584.68-42,861.18-24,508.09
归属于少数股东的综合收益总额-2,286.14-13,421.91-7,860.97-5,297.78-2,471.02
下载全部历史数据到excel中 返回页顶